Skip to main content
. Author manuscript; available in PMC: 2018 Aug 12.
Published in final edited form as: Semin Pediatr Neurol. 2017 Aug 12;24(3):229–239. doi: 10.1016/j.spen.2017.08.001

Table 1.

Multiplicity of Biomarker Types and Applications

Type Definition/Application
Combinatorial Panel- or pattern-based
Diagnostic Disease-specific
Differentiation Efficacy or safety of drugs within same class
Efficacy Reflects positive outcome of a treatment
Exploratory Delimited, may be driven by discovery, not hypothesis
Pharmacodynamic Contrasting pharmacodynamic patterns may offer utility for treatment (optimal dose?)
Prognostic Predict course of disease
Predictive Provides information on obtaining response to treatment (optimal drug?)
Qualified The data support its use for stated purpose
Risk Can be used for risk stratification
Toxicity Avoid/monitor potential toxic effects
Screening Early disease detection
Staging Differentiates different stages, activity, and subtypes of disease
Stand-alone A single biomarker sufficient for purpose by itself
Stratification Select best treatment for given patient
Surrogate Intended as substitute for clinical endpoint
Translational Can be used in pre-clinical and clinical studies